These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27284698)

  • 1. Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial.
    Abdalrhim AD; Marroush TS; Austin EE; Gersh BJ; Solak N; Rizvi SA; Bailey KR; Kullo IJ
    PLoS One; 2016; 11(6):e0156965. PubMed ID: 27284698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina.
    Minoretti P; Falcone C; Calcagnino M; Emanuele E; Buzzi MP; Coen E; Geroldi D
    Eur Heart J; 2006 Apr; 27(7):802-7. PubMed ID: 16421174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.
    Georgiadou P; Iliodromitis EK; Kolokathis F; Varounis C; Gizas V; Mavroidis M; Capetanaki Y; Boudoulas H; Kremastinos DT
    Eur J Clin Invest; 2010 Apr; 40(4):288-93. PubMed ID: 20192976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery.
    Sbarouni E; Georgiadou P; Chatzikyriakou S; Analitis A; Chaidaroglou A; Degiannis D; Voudris V
    Dis Markers; 2016; 2016():1868739. PubMed ID: 27597799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.
    Bjerre M; Pedersen SH; Møgelvang R; Lindberg S; Jensen JS; Galatius S; Flyvbjerg A
    Eur J Prev Cardiol; 2013 Dec; 20(6):922-9. PubMed ID: 23613225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is elevated in patients with mitral annulus calcification independent from classic cardiovascular risk factors.
    Sponder M; Reuter C; Fritzer-Szekeres M; Litschauer B; Binder T; Strametz-Juranek J
    BMC Cardiovasc Disord; 2016 Jun; 16():132. PubMed ID: 27283399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
    Berezin AE; Kremzer AA
    Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
    Krum H; Elsik M; Schneider HG; Ptaszynska A; Black M; Carson PE; Komajda M; Massie BM; McKelvie RS; McMurray JJ; Zile MR; Anand IS
    Circ Heart Fail; 2011 Sep; 4(5):561-8. PubMed ID: 21750125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of osteopontin on the cardiovascular outcomes in patients with stable coronary artery disease.
    Cheong KI; Leu HB; Wu CC; Yin WH; Wang JH; Lin TH; Tseng WK; Chang KC; Chu SH; Yeh HI; Chen JW; Wu YW;
    J Formos Med Assoc; 2023 Apr; 122(4):328-337. PubMed ID: 36494313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients].
    Czyzewska-Buczyńska A; Zuk N; Bałasz S; Witkiewicz W
    Przegl Lek; 2013; 70(3):102-5. PubMed ID: 24003660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease.
    Sponder M; Fritzer-Szekeres M; Marculescu R; Litschauer B; Strametz-Juranek J
    Heart Vessels; 2016 Oct; 31(10):1603-8. PubMed ID: 26661073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.